Get Premium to unlock powerful stock data
NAS:SAVA (USA)  
Cassava Sciences Inc logo

Cassava Sciences Inc

$ 29.75 +0.28 (+0.95%) 11:08 PM EST
P/E:
At Loss
P/B:
4.97
Market Cap:
$ 1.19B
Enterprise V:
$ 971.70M
Volume:
392.43K
Avg Vol (2M):
1.24M
Also Trade In:
Volume:
392.43K
Market Cap $:
1.19B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.24M
Enterprise Value $:
971.70M
PB Ratio:
4.97
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Cassava Sciences Inc
NAICS : 325412 SIC : 2834
7801 N. Capital of Texas Highway, Suite 260, Austin, TX, USA, 78731
Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.
Name Current Vs Industry Vs History
Cash-To-Debt 984.47
Equity-to-Asset 0.97
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 2.38
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 58.11
9-Day RSI 58.06
14-Day RSI 56.75
6-1 Month Momentum % -37.99
12-1 Month Momentum % -67.87

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 32.73
Quick Ratio 32.73
Cash Ratio 30.89

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -32.5

Financials (Next Earnings Date:2022-08-03 Est.)

SAVA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:SAVA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.16
Beta 0.35
Volatility % 105.95
14-Day RSI 56.75
14-Day ATR ($) 2.570472
20-Day SMA ($) 27.8135
12-1 Month Momentum % -67.87
52-Week Range ($) 15.72 - 146.16
Shares Outstanding (Mil) 40.08

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cassava Sciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More